Literature DB >> 29264628

[Perioperative handling of immunosuppressive therapy].

J Wagner1, V Luber2, J F Lock1, U A Dietz1, S Lichthardt1, N Matthes1, K Krajinovic1, C-T Germer1,3, S Knop2,3, A Wiegering4,5.   

Abstract

Every year 16 million operations are performed in Germany. Many patients have an autoimmune disorder, for example rheumatoid arthritis, psoriasis or chronic inflammatory bowel disease, which requires treatment. Immunosuppressants are widely applied. Physicians must make a risk-adapted decision whether the immunosuppressant medication can be continued perioperatively or if certain drugs must be paused and if so, with what risks. The handling of immunosuppressants during the perioperative period is very relevant as many patients, for example with rheumatoid arthritis are in need of a hip or knee replacement or patients with inflammatory bowel disease need an operation due to the chronic illness. The interruption of an immunosuppressant therapy should be discussed in an interdisciplinary board according to the underlying disease, because the continuation of immunosuppressants perioperatively can lead to an increased rate of complications, especially wound healing disorders. If a patient is on a glucocorticoid therapy the following must be considered: during the perioperative period the body has an increased demand for glucocorticoids due to the stress reaction. If glucocorticoids are administered in a dosage of more than 7.5 mg/day equivalent of prednisolone this stress reaction is inhibited. Thus, in these cases a perioperative substitution with hydrocortisone is recommended.

Entities:  

Keywords:  Chronic medication; Glucocorticoids; Immunosuppressants; Perioperative period; Preoperative pause

Mesh:

Substances:

Year:  2018        PMID: 29264628     DOI: 10.1007/s00104-017-0529-6

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  34 in total

1.  Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications.

Authors:  Christopher Mascarenhas; Robert Nunoo; Theodor Asgeirsson; Rachelle Rivera; Don Kim; Rebecca Hoedema; Nadav Dujovny; Martin Luchtefeld; Alan T Davis; Ryan Figg
Journal:  Am J Surg       Date:  2012-03       Impact factor: 2.565

2.  [Updated German clinical practice guideline on "Diagnosis and treatment of Crohn's disease" 2014].

Authors:  J C Preiß; B Bokemeyer; H J Buhr; A Dignaß; W Häuser; F Hartmann; K R Herrlinger; B Kaltz; P Kienle; W Kruis; T Kucharzik; J Langhorst; S Schreiber; B Siegmund; A Stallmach; E F Stange; J Stein; J C Hoffmann
Journal:  Z Gastroenterol       Date:  2014-12-04       Impact factor: 2.000

3.  Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study.

Authors:  Takayuki Yamamoto; Antonino Spinelli; Yasuo Suzuki; Rogerio Saad-Hossne; Fabio Vieira Teixeira; Idblan Carvalho de Albuquerque; Rodolff Nunes da Silva; Ivan Folchini de Barcelos; Ken Takeuchi; Akihiro Yamada; Takahiro Shimoyama; Lorete Maria da Silva Kotze; Matteo Sacchi; Silvio Danese; Paulo Gustavo Kotze
Journal:  United European Gastroenterol J       Date:  2015-08-06       Impact factor: 4.623

4.  Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro.

Authors:  S Jung; S Fehr; J Harder-d'Heureuse; B Wiedenmann; A U Dignass
Journal:  Scand J Gastroenterol       Date:  2001-09       Impact factor: 2.423

5.  Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs.

Authors:  Shigeki Momohara; Kosei Kawakami; Takuji Iwamoto; Koichiro Yano; Yu Sakuma; Ryo Hiroshima; Hitoshi Imamura; Ikuko Masuda; Asami Tokita; Katsunori Ikari
Journal:  Mod Rheumatol       Date:  2011-02-12       Impact factor: 3.023

6.  Management of patients with psoriasis treated with biological drugs needing a surgical treatment.

Authors:  Antonella Fabiano; Clara De Simone; Paolo Gisondi; Stefano Piaserico; Claudia Lasagni; Giovanni Pellacani; Andrea Conti
Journal:  Drug Dev Res       Date:  2014-11       Impact factor: 4.360

7.  Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.

Authors:  Chelliah R Selvasekar; Robert R Cima; David W Larson; Eric J Dozois; Jeffrey R Harrington; William S Harmsen; Edward V Loftus; William J Sandborn; Bruce G Wolff; John H Pemberton
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

8.  The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease.

Authors:  Geoffrey C Nguyen; Ahmad Elnahas; Timothy D Jackson
Journal:  J Crohns Colitis       Date:  2014-08-05       Impact factor: 9.071

9.  Factors which influenced postoperative complications in patients with ulcerative colitis or Crohn's disease of the colon on corticosteroids.

Authors:  J R Allsop; E C Lee
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

10.  Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery.

Authors:  Liliana Bordeianou; Hiroko Kunitake; Paul Shellito; Richard Hodin
Journal:  Int J Colorectal Dis       Date:  2009-10-02       Impact factor: 2.571

View more
  2 in total

Review 1.  [Immunosuppressive treatment and bone healing].

Authors:  Dagmar Horn; Christoph Klaas; Michael Raschke; Richard Stange
Journal:  Unfallchirurg       Date:  2019-07       Impact factor: 1.000

2.  High-Risk Perioperative Medications in the Chinese Elderly Population.

Authors:  Shuying Wang; Weifang Ren; Xiaofang Tan; Xiaoqun Lv; Yujuan Liu; Yuan Gong
Journal:  Clin Interv Aging       Date:  2021-06-24       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.